Antimicrobial resistance (AMR) constitutes a serious risk to health worldwide with major economic impacts. Resistance genes are present in humans, animals and the environment and bacteria carrying resistance genes spread between them. This needs to be considered when designing integrated AMR surveillance strategies. Several integrated surveillance strategies exist globally but their effectiveness and economic efficiency remain to be evaluated. The aim of the project is to assess the value of integrated AMR surveillance systems in the UK.
Our objective is to produce a specific tool to evaluate the performance of AMR integrated surveillance systems, which will allow us to assess whether integrated surveillance generates an added value. This will enable policy makers to make the most cost effective decisions. By considering the different monetary and non-monetary benefits and costs resulting from the integration, this project will provide information on the cost-effectiveness of surveillance integration and identify areas where improvements can be made and efficiency increased.
This project is funded by a Bloomsbury Studentship http://www.bloomsbury.ac.uk/
Project team: Houda Bennani, Barbara Haesler, Laura Cornelsen (LSHTM), Katharina Staerk